Cetrorelix

Chemical formula: C₇₀H₉₂ClN₁₇O₁₄  Molecular mass: 1,431.038 g/mol  PubChem compound: 25074887

Therapeutic indications

Cetrorelix is indicated for:

Prevention of premature ovulation

Population group: women, only adults (18 - 65 years old)

Prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick-up and assisted reproductive techniques.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Cetrorelix is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

Severe renal impairment

at least one of

Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: CETROTIDE Powder and solvent for solution for injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈